Status | Study |
Withdrawn |
Study Name: Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET] Condition: Squamous Cell Carcinoma of the Penis Date: 2013-11-18 Interventions: Procedure: MRI-PET Participants will have an MRI-PET scan (the Index test) in addition to the procedures |
Recruiting |
Study Name: Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis Condition: Penile Neoplasms Carcinoma, Squamous Cell Date: 2012-11-13 Interventions: Drug: Dacomitinib PF-299804 will be administered orally at a dose of 45 mg/day continuously until surger |
Completed |
Study Name: Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer Condition: Melanoma Merkel Cell Carcinoma Squamous Cell Carcinoma Date: 2012-01-28 Interventions: Procedure: Videoscopic procedure |
Completed |
Study Name: Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis Condition: Penile Cancer Date: 2007-08-06 Interventions: Drug: Ifosfamide 1200 mg/m^2 B |
Completed |
Study Name: Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer Condition: Penile Cancer Date: 2003-08-06 Interventions: Drug: cisplatin Drug: irinotecan hydrochlo |
Terminated |
Study Name: S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED) Condition: Penile Cancer Date: 2003-04-07 Interventions: Drug: docetaxel |